In Reply - Hormones and COVID-19.

We thank Dr Elagizi and colleagues for taking the time to review our recent publication in Mayo Clinic Proceedings.1MacArthur T.A. Goswami J. Ramachandran D. et al.Estradiol and dihydrotestosterone levels in COVID-19 patients.Mayo Clin Proc. 2023; 98: 559-568Abstract Full Text Full Text PDF Scopus (3) Google Scholar We appreciate the thoughtful and well-researched reply, and we very sincerely appreciate the support of our work and findings. We agree that further study into potential hormonal advantages in COVID-19 as well as in other pathologic conditions, including trauma, is warranted and may open doors for alternative therapeutic and prophylactic opportunities in the future that can be tailored to specific patient populations. The reply to our study from Dr Elagizi and colleagues has added even more valuable background and supporting evidence in this area. We thank them for the thoughtful consideration of our work. The authors report no competing interests. Hormones and COVID-19Mayo Clinic ProceedingsVol. 98Issue 7PreviewWe read with interest the recent study of Dr Taleen A. MacArthur and colleagues1 from Mayo Clinic regarding hormone levels in their patients with coronavirus disease 2019 (COVID-19) compared with healthy volunteers, and we share their interest that hormones may have an impact on prognosis in this potentially fatal viral infection. Full-Text PDF